These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36443593)

  • 1. Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies.
    Iyer P; Dobson R
    Neurol Ther; 2023 Feb; 12(1):1-10. PubMed ID: 36443593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendations about Multiple Sclerosis Management during Pregnancy, Partum and Post-Partum: Consensus Position of the Portuguese Multiple Sclerosis Study Group].
    Batista S; Martins da Silva A; Sá MJ; Sousa L; De Sá J; Pedrosa R; Cerqueira J; Pinheiro J; Abreu P; Simões RM; Vale J
    Acta Med Port; 2020 Sep; 33(9):611-621. PubMed ID: 32893778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations About Multiple Sclerosis Management During Pregnancy, Partum and Post-Partum: Consensus Position of The Portuguese Multiple Sclerosis Study Group and The Portuguese Society of Obstetrics and Maternal-Fetal Medicine].
    Batista S; Silva AM; Sá MJ; Sousa L; De Sá J; Pedrosa R; Cerqueira J; Pinheiro J; Abreu P; Simões RM; Dias E; Veríssimo C; Vale J
    Acta Med Port; 2018 Dec; 31(12):785-795. PubMed ID: 30684378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the Myths.
    Graham EL; Bove R; Costello K; Crayton H; Jacobs DA; Shah S; Sorrell F; Stoll SS; Houtchens MK
    Neurol Clin Pract; 2024 Apr; 14(2):e200253. PubMed ID: 38585436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies.
    Simone IL; Tortorella C; Ghirelli A
    Front Neurol; 2021; 12():697974. PubMed ID: 34276545
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide.
    Gklinos P; Dobson R
    Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus.
    Iyer P; Wiles K; Ismail A; Nanda S; Murray K; Hughes S; Ford HL; Pearson OR; White S; Bonham N; Hoyle N; Witts J; Middleton R; Brex PA; Rog D; Dobson R
    Mult Scler; 2023 Mar; 29(3):395-406. PubMed ID: 36740816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies.
    Burtchell J; Clemmons D; Clemmons J; Sabutis T; Rosenberg A; Graves J; Sweeney ML; Kramer J; Ziehn M; Brown B; Weiss JL; Obeidat AZ
    Neurol Ther; 2022 Sep; 11(3):955-979. PubMed ID: 35608740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review.
    Capone F; Albanese A; Quadri G; Di Lazzaro V; Falato E; Cortese A; De Giglio L; Ferraro E
    Front Neurol; 2022; 13():851413. PubMed ID: 35493841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists.
    Saposnik G; Andhavarapu S; Fernández Ó; Kim HJ; Wiendl H; Foss M; Zuo F; Havrdová EK; Celius EG; Caceres F; Magyari M; Bermel R; Costa A; Terzaghi M; Kalincik T; Popescu V; Amato MP; Montalban X; Oh J
    Mult Scler Relat Disord; 2022 Jan; 57():103389. PubMed ID: 35158479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis.
    Vaughn C; Bushra A; Kolb C; Weinstock-Guttman B
    CNS Drugs; 2018 Feb; 32(2):161-178. PubMed ID: 29508244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy.
    Villaverde-González R
    Degener Neurol Neuromuscul Dis; 2022; 12():1-21. PubMed ID: 35023987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert opinion on the pharmacological management of multiple sclerosis in women of childbearing age in Iraq.
    Hassoun HK; Almahdawi A; Al-Bajalan SJ; Sheaheed NM; Kamil MAS; Saeed Ridha SM; Al-Owath MMH; Abd MF; Al-Khammasi B; Hasan ZN; Hatem AO; Al-Naqshbandi M; Rieckmann P
    Heliyon; 2023 Feb; 9(2):e13350. PubMed ID: 36816245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Family planning in multiple sclerosis: conception, pregnancy, breastfeeding].
    Rózsa C
    Ideggyogy Sz; 2020 May; 73(05-06):161-169. PubMed ID: 32579305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Sclerosis and Family Planning: A Survey Study of the Patient Experience.
    Kelly EE; Engel C; Pearsall R; Brenton JN; Bove R; Oh U; Goldman MD
    Neurol Clin Pract; 2024 Feb; 14(1):e200222. PubMed ID: 38148835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines.
    Dobson R; Dassan P; Roberts M; Giovannoni G; Nelson-Piercy C; Brex PA
    Pract Neurol; 2019 Apr; 19(2):106-114. PubMed ID: 30612100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of disease-modifying drugs during pregnancy and breastfeeding.
    Dobson R; Hellwig K
    Curr Opin Neurol; 2021 Jun; 34(3):303-311. PubMed ID: 33709977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical review: Lactation and use of DMTs in women with MS.
    Hsu S; Balan A; Bove R
    Mult Scler; 2024 Sep; ():13524585241257843. PubMed ID: 39348090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.